The global blood gas analyzers market is expected to grow at a CAGR of 4.6% from 2016 to 2021, to reach USD 636.0 million by 2021. A number of factors, such as the growing number of patients being treated in ICUs, NICUs, and emergency departments, and the increasing adoption of technologically advanced biosensors and data analysis software for developing next-generation blood gas analyzers are expected to drive the growth of this market in the coming years.

Download PDF Brochure @ http://www.marketsandmarkets.com/pdfdownload.asp?id=242278963

The rising demand for point-of-care analyzers is another major factor driving the growth of the blood gas analyzers market. Products such as epoc, ABL90, cobas b 123, and GEM 4000 are expected to grow at high CAGRs during the forecast period (2016-2021) owing to advantages such as portability and faster turnaround times offered by them. In the near future, the commercialization of innovative POC blood gas analyzers based on miniaturized sensors will emerge as a significant opportunity, since the use of next-generation blood gas analyzers will reduce both cost and time involved in processes. Also, in the coming years, there will be a significant demand for blood gas analyzers with wired or wireless connectivity options, advanced calculation algorithms, enhanced user-friendly features (such as color touchscreens and graphical guidance systems), advanced sensor technologies, and auto-calibration features.

The introduction of new-generation blood gas analyzers based on advanced sensors and the growing need for blood gas analyzers that are compatible with electronic medical record systems are some of the major factors expected to support market growth in the coming years. Such technologically advanced blood gas analyzers allow clinicians to use devices near patients’ bedsides, where blood gases, pH, co-oximetry, electrolytes, and metabolites can be easily tested within a very short turnaround time. In the coming five years, growth in the blood gas analyzers market is expected to be centered at the APAC region. Factors such as growing initiatives by market players, increasing patient population base, and rising number of partnerships and joint ventures are driving the growth of the blood gas analyzers market in the Asia-Pacific region.

About MarketsandMarkets

MarketsandMarkets is the world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to a multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.

Contact:
Mr. Rohan
Markets and Markets
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune, Maharashtra 411013, India
1-888-600-6441
Email: [email protected]